Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Machine Learning Provides Individualized Prediction of Outcomes after First Complete Remission in Adult AML Patients - Results from the Harmony Platform

Blood (2023) 142 (Supplement 1): 62.

https://doi.org/10.1182/blood-2023-183029

Published: 2023

Journal Articles

Long-Term Follow-up of AML Patients Treated Intensively before the Era of Targeted Agents. a Big Data Analysis from the Harmony Collaboration

Blood (2022) 140 (Supplement 1): 6053–6055.

https://doi.org/10.1182/blood-2022-165088

Published: 2022

Journal Articles

Enabling the Implementation of Next-Generation Sequencing into Clinical Diagnosis: Nemhesys Project

Blood (2022) 140 (Supplement 1): 13122–13124.

https://doi.org/10.1182/blood-2022-163285

Published: 2022

Journal Articles

Rearrangements Involving 11q23/ KMT2A : Mutational Landscape and Prognostic Implications - Results of the Harmony Alliance AML Database

Blood (2022) 140 (Supplement 1): 551–554.

https://doi.org/10.1182/blood-2022-167480

Published: 2022

Journal Articles

Machine Learning Allows the Identification of New Co-Mutational Patterns with Prognostic Implications in NPM1 Mutated AML - Results of the European Harmony Alliance

Blood (2022) 140 (Supplement 1): 739–742.

https://doi.org/10.1182/blood-2022-167138

Published: 2022

Journal Articles

Harmony Alliance Provides a Machine Learning Researching Tool to Predict the Risk of Relapse after First Remission in AML Patients Treated without Allogeneic Haematopoietic Stem Cell Transplantation

Blood (2021) 138 (Supplement 1): 4041.

https://doi.org/10.1182/blood-2021-149521

Published: 2021

Journal Articles

Impact of Gender on Molecular AML Subclasses - a Harmony Alliance Study

Tommaso Matteuzzi, Daniele Dall'Olio, Eric Sträng, Alessandra Merlotti, Javier Martinez Elicegui, Axel Benner, Maral Saadati, Julia Krzykalla, Caroline A. Heckman, Ana Heredia Casanoves, Jurjen Versluis, María Abáigar, Alberto Hernandez-Sanchez, Laura Jamilis, Peter JM Valk, Klaus H. Metzeler, Rosa Ayala, Joaquin Martinez Lopez, Herve Dombret, Pau Montesinos, Jorge Sierra, Claude Preudomme, Frederick Damm, Ken I Mills, Raúl Azibeiro Melchor, Jiří Mayer, Christian Thiede, Maria Teresa Voso, Sergio Amadori, Guillermo Sanz, Frederico Calado, Konstanze Döhner, Verena I Gaidzik, Michael Heuser, Torsten Haferlach, Marta Sobas, Amin T. Turki, Dirk Reinhardt, Rubén Villoria Medina, Michel van Speybroeck, Renate Schulze-Rath, Jesús M Hernández Rivas, Brian J.P Huntly, Hartmut Döhner, Gert J. Ossenkoppele, Castellani Gastone, Lars Bullinger

Blood (2021) 138 (Supplement 1): 3438.

https://doi.org/10.1182/blood-2021-152215

Published: 2021

Journal Articles

Does RAD21 Co-Mutation Have a Role in DNMT3A Mutated AML? Results of Harmony Alliance AML Database

Blood (2021) 138 (Supplement 1): 608.

https://doi.org/10.1182/blood-2021-150766

Published: 2021

Journal Articles

Genomic Instability and a Preferential Involvement of Ras Pathway in the Myelodysplastic Syndromes Evolution to Secondary Acute Myeloid Leukemia

Blood (2018) 132 (Supplement 1): 3082.

https://doi.org/10.1182/blood-2018-99-118224

Published: 2018

Journal Articles

Patterns of Clonal Evolution Assessed By Whole Exome Sequencing during Progression from MDS to AML Are Related to Therapy

María Abáigar, PhD, Jesús M Hernández-Sánchez, David Tamborero, PhD, Marta Martín-Izquierdo, María Díez-Campelo, MD, María Hernández-Sánchez, Fernando Ramos, MD, Marta Megido, Carlos Aguilar, Eva Lumbreras, Isabel Recio, Carmen Olivier, Cristina Robledo, Rocío Benito, PhD, Nuria Lopez-Bigas, Consuelo Del Cañizo, MD PhD, Jesús María Hernández-Rivas, MD

Blood (2016) 128 (22): 4309.

https://doi.org/10.1182/blood.V128.22.4309.4309

Published: 2016

Journal Articles

Analysis of Clonal Evolution in Chronic Lymphocytic Leukemia from Inactive to Symptomatic Disease Prior Treatment Using Whole-Exome Sequencing

María Hernández-Sánchez, Lenka Radova, PhD, Jana Kotaskova, David Tamborero, PhD, Ana E Rodriguez, PhD, Karla Plevova, PhD, María Abáigar, PhD, Vasileios Bikos, Rocío Benito, PhD, Sylvia Takacova, PhD, Miguel Quijada, Ana África Martín, MD, Miguel Alcoceba, BSc, PhD, Alfonso García de Coca, Michael Doubek, Marcos González, MD PhD, Nuria Lopez-Bigas, PhD, Sarka Pospisilova, Jesús María Hernández-Rivas, MD

Blood (2016) 128 (22): 3206.

https://doi.org/10.1182/blood.V128.22.3206.3206

Published: 2016

Journal Articles

Could Chronic Gvhd Overcome the Poor Prognosis of Patients with MDS and TP53 Undergoing Allogeneic HSCT?

Juan Carlos Caballero, MD, Mercedes Sánchez-Barba, Mónica Del Rey, Kamila Janusz, Eva Lumbreras, María Abáigar, Robledo Cristina, Andrés Jerez, Esperanza Such, PhD, Guillermo Sanz, MD PhD, Cristina Calderon, MD, David Valcarcel, MD PhD, Jesus Maria Hernandez-Rivas, PhD, María Consuelo Cañizo, MD PhD, María Díez-Campelo, MD PhD

Blood (2015) 126 (23): 2890.

https://doi.org/10.1182/blood.V126.23.2890.2890

Published: 2015

Journal Articles

Hidden DNA Copy Number Alterations and Mutations in IKZF1 , TP53 , CRLF2 and JAK2 Genes Are Associated with a Poor Prognosis in B-Progenitor Acute Lymphoblastic Leukemia

Blood (2014) 124 (21): 1082.

https://doi.org/10.1182/blood.V124.21.1082.1082

Published: 2014

NARROW

Machine Learning Provides Individualized Prediction of Outcomes after First Complete Remission in Adult AML Patients - Results from the Harmony Platform

Long-Term Follow-up of AML Patients Treated Intensively before the Era of Targeted Agents. a Big Data Analysis from the Harmony Collaboration

Enabling the Implementation of Next-Generation Sequencing into Clinical Diagnosis: Nemhesys Project

Rearrangements Involving 11q23/ KMT2A : Mutational Landscape and Prognostic Implications - Results of the Harmony Alliance AML Database

Machine Learning Allows the Identification of New Co-Mutational Patterns with Prognostic Implications in NPM1 Mutated AML - Results of the European Harmony Alliance

Harmony Alliance Provides a Machine Learning Researching Tool to Predict the Risk of Relapse after First Remission in AML Patients Treated without Allogeneic Haematopoietic Stem Cell Transplantation

Impact of Gender on Molecular AML Subclasses - a Harmony Alliance Study

Does RAD21 Co-Mutation Have a Role in DNMT3A Mutated AML? Results of Harmony Alliance AML Database

Genomic Instability and a Preferential Involvement of Ras Pathway in the Myelodysplastic Syndromes Evolution to Secondary Acute Myeloid Leukemia

Patterns of Clonal Evolution Assessed By Whole Exome Sequencing during Progression from MDS to AML Are Related to Therapy

Analysis of Clonal Evolution in Chronic Lymphocytic Leukemia from Inactive to Symptomatic Disease Prior Treatment Using Whole-Exome Sequencing

Could Chronic Gvhd Overcome the Poor Prognosis of Patients with MDS and TP53 Undergoing Allogeneic HSCT?

Hidden DNA Copy Number Alterations and Mutations in IKZF1 , TP53 , CRLF2 and JAK2 Genes Are Associated with a Poor Prognosis in B-Progenitor Acute Lymphoblastic Leukemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only